LIFECORE BIOMEDICAL, INC. Marketable Securities (Current)
LIFECORE BIOMEDICAL, INC. (LFCR) had Marketable Securities (Current) of $1.30 million as of 2013-08-25, per its 10-Q filed 2013-09-26.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:MarketableSecuritiesCurrent · last filed 2014-08-01
- 2013-08-25: Marketable Securities, Current $1.30M.
- 2013-05-26: Marketable Securities, Current $1.54M.
- 2013-02-24: Marketable Securities, Current $3.79M.
- 2012-11-25: Marketable Securities, Current $1.96M.
| Period end | Marketable Securities, Current |
|---|---|
| 2013-08-25 | $1.30M 10-Q · filed 2013-09-26 |
| 2013-05-26 | $1.54M 10-K · filed 2014-08-01 |
| 2013-02-24 | $3.79M 10-Q · filed 2013-04-04 |
| 2012-11-25 | $1.96M 10-Q · filed 2013-01-04 |
| 2012-08-26 | $756.00K 10-Q/A · filed 2013-01-02 |
| 2012-02-26 | $25.09M 10-Q · filed 2012-03-28 |
| 2011-11-27 | $24.24M 10-Q · filed 2012-01-05 |
| 2011-08-28 | $32.11M 10-Q · filed 2011-10-05 |
| 2011-05-29 | $28.12M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |